FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198175031> ?p ?o ?g. }

• W3198175031 endingPage "S391" @default.
• W3198175031 startingPage "S391" @default.
• W3198175031 abstract "Context Treatment delays can compromise outcomes in aggressive hematological malignancies primarily treated with chemotherapy. Due to the burden of the COVID-19 pandemic on healthcare systems, there is a potential risk of delayed therapy of various diseases, including cancers. However, efforts were made in our center (despite being a COVID-19-designated hospital) to ensure that “curative-intent” treatment for cancers should not be affected, and hence, the diagnostic (pathology, imaging) and therapeutic services for hematological cancers were continued. In this study we analyzed the impact of the COVID-19 pandemic on diagnosis and treatment procedures and survival outcomes among patients with Diffuse Large B-Cell Lymphoma (DLBCL). Objective To compare treatment duration among patients with DLBCL during the COVID-19 period with those treated prior to the onset of the pandemic. Design Retrospective record-based study. Setting Regional cancer center, JIPMER, India. Patients or Other Participants The medical records of treatment naive DLBCL patients registered between January 2019 and December 2019 (Group 1; pre-pandemic) and January 2020 until December 2020 (Group 2: during pandemic) were accessed, and the following data were collected: baseline characteristics, time from diagnosis to treatment, time for completion of planned chemotherapy, and proportion of patients defaulting treatment. Interventions Not applicable, as it is a retrospective record-based study. Main Outcome Measures Primary endpoint was treatment duration during the COVID-19 period with those treated prior to the onset of the pandemic. Results A total of 67 patients were identified (Group 1: 46 (69%) Group 2: 21 (31%). The median age of patients registered in 2019 and 2020 were 50 (39–64) years and 44 (34–62) years, respectively. The duration between diagnosis to start of treatment for patients in 2019 and 2020 was 28 (13–43) days and 19 (11-40) days respectively. The duration between start of treatment to end of treatment for patients in 2019 and 2020 was 119 (107–137) days and 121 (101–145) days, respectively. Conclusions There was no significant difference in treatment duration among DLBCL patients during the COVID-19 pandemic. Treatment completion rates were similar." @default.
• W3198175031 created "2021-09-13" @default.
• W3198175031 creator A5004304550 @default.
• W3198175031 creator A5008818538 @default.
• W3198175031 creator A5018712940 @default.
• W3198175031 creator A5024252441 @default.
• W3198175031 creator A5035381661 @default.
• W3198175031 creator A5064525438 @default.
• W3198175031 creator A5073696738 @default.
• W3198175031 date "2021-09-01" @default.
• W3198175031 modified "2023-09-24" @default.
• W3198175031 title "ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study" @default.
• W3198175031 doi "https://doi.org/10.1016/s2152-2650(21)01888-7" @default.
• W3198175031 hasPublicationYear "2021" @default.
• W3198175031 type Work @default.
• W3198175031 sameAs 3198175031 @default.
• W3198175031 citedByCount "1" @default.
• W3198175031 countsByYear W31981750312022 @default.
• W3198175031 crossrefType "journal-article" @default.
• W3198175031 hasAuthorship W3198175031A5004304550 @default.
• W3198175031 hasAuthorship W3198175031A5008818538 @default.
• W3198175031 hasAuthorship W3198175031A5018712940 @default.
• W3198175031 hasAuthorship W3198175031A5024252441 @default.
• W3198175031 hasAuthorship W3198175031A5035381661 @default.
• W3198175031 hasAuthorship W3198175031A5064525438 @default.
• W3198175031 hasAuthorship W3198175031A5073696738 @default.
• W3198175031 hasBestOaLocation W31981750311 @default.
• W3198175031 hasConcept C116675565 @default.
• W3198175031 hasConcept C126322002 @default.
• W3198175031 hasConcept C143998085 @default.
• W3198175031 hasConcept C159047783 @default.
• W3198175031 hasConcept C167135981 @default.
• W3198175031 hasConcept C2779134260 @default.
• W3198175031 hasConcept C3006700255 @default.
• W3198175031 hasConcept C3007834351 @default.
• W3198175031 hasConcept C3008058167 @default.
• W3198175031 hasConcept C524204448 @default.
• W3198175031 hasConcept C71924100 @default.
• W3198175031 hasConcept C89623803 @default.
• W3198175031 hasConceptScore W3198175031C116675565 @default.
• W3198175031 hasConceptScore W3198175031C126322002 @default.
• W3198175031 hasConceptScore W3198175031C143998085 @default.
• W3198175031 hasConceptScore W3198175031C159047783 @default.
• W3198175031 hasConceptScore W3198175031C167135981 @default.
• W3198175031 hasConceptScore W3198175031C2779134260 @default.
• W3198175031 hasConceptScore W3198175031C3006700255 @default.
• W3198175031 hasConceptScore W3198175031C3007834351 @default.
• W3198175031 hasConceptScore W3198175031C3008058167 @default.
• W3198175031 hasConceptScore W3198175031C524204448 @default.
• W3198175031 hasConceptScore W3198175031C71924100 @default.
• W3198175031 hasConceptScore W3198175031C89623803 @default.
• W3198175031 hasLocation W31981750311 @default.
• W3198175031 hasLocation W31981750312 @default.
• W3198175031 hasOpenAccess W3198175031 @default.
• W3198175031 hasPrimaryLocation W31981750311 @default.
• W3198175031 hasRelatedWork W3017171836 @default.
• W3198175031 hasRelatedWork W3025176011 @default.
• W3198175031 hasRelatedWork W3027835066 @default.
• W3198175031 hasRelatedWork W3032320397 @default.
• W3198175031 hasRelatedWork W3033635008 @default.
• W3198175031 hasRelatedWork W3152606407 @default.
• W3198175031 hasRelatedWork W4280491013 @default.
• W3198175031 hasRelatedWork W4308017287 @default.
• W3198175031 hasRelatedWork W3107152225 @default.
• W3198175031 hasRelatedWork W3183300108 @default.
• W3198175031 hasVolume "21" @default.
• W3198175031 isParatext "false" @default.
• W3198175031 isRetracted "false" @default.
• W3198175031 magId "3198175031" @default.
• W3198175031 workType "article" @default.